LeserbriefKommentar
HER2-positive apocrine carcinoma of the breast and PIK3CA mutations
Breast Cancer · 2026-07 · 33 (4) · 945-946
DOI: 10.1007/s12282-026-01872-1 ↗Kurz gefasst
Leserbrief in der Zeitschrift Breast Cancer, online erschienen am 20.05.2026. Verfasst von Semir Vranic. Beteiligte Einrichtung: College of Medicine, QU Health, Qatar University, Doha, 2713, Qatar. semir.vranic@gmail.com. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- College of Medicine, QU Health, Qatar University, Doha, 2713, Qatar. semir.vranic@gmail.com.
Zitieren
APA
Vranic, S. (2026). HER2-positive apocrine carcinoma of the breast and PIK3CA mutations. Breast Cancer, 33(4), 945-946. https://doi.org/10.1007/s12282-026-01872-1
Vancouver
Vranic S. HER2-positive apocrine carcinoma of the breast and PIK3CA mutations. Breast Cancer. 2026;33(4):945-946. doi:10.1007/s12282-026-01872-1
BibTeX
@article{Vranic2026,
author = {Vranic, Semir},
title = {HER2-positive apocrine carcinoma of the breast and PIK3CA mutations},
journal = {Breast Cancer},
year = {2026},
volume = {33},
number = {4},
pages = {945--946},
doi = {10.1007/s12282-026-01872-1}
}
EUVIMED